The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Khaes B.L.

URAMN nauchno-issledovatel'skiĭ institut kompleksnykh problem serdechno-sosudistykh zabolevaniĭ SO RAMN, Kemerovo

Plotnikov G.P.

Research Institute for Complex Issues of Cardiovascular Diseases 6, Sosnovy Blvd, 650002, Kemerovo, Russia

Fanaskova E.V.

FGBU "NII kompleksnykh problem serdechno-sosudistykh zabolevaniĭ" SO RAMN, Kemerovo

Shukevich D.L.

Kemerovskaia oblastnaia klinicheskaia bol'nitsa

Barbarash L.S.

State Research Institute for Complex Issues of Cardiovascular Diseases Municipal Budget Healthcare Institution, Kemerovo, Russia

Authors:

Khaes B.L., Plotnikov G.P., Fanaskova E.V., Shukevich D.L., Barbarash L.S.

More about the authors

Journal: Russian Journal of Cardiology and Cardiovascular Surgery. 2016;9(6): 55‑60

Read: 870 times

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Khaes BL, Plotnikov GP, Fanaskova EV, Shukevich DL, Barbarash LS. . Russian Journal of Cardiology and Cardiovascular Surgery. 2016;9(6):55‑60. (In Russ.)

ЭндоКард
Подписка 2026 Кардиология и сердечно-сосудистая хирургия (Russian Journal of Cardiology and Cardiovascular Surgery)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

Aim. To assess an effectiveness of patient-oriented selection of extracorporeal circuit in adults. Material and methods. Prospective non-randomized study included 113 patients undergoing cardiac surgery under extracorporeal circulation. High- (priming volume 1200—1400 ml) with cold blood cardioplegia or «small adult» low-prime volume oxygenators (950 ml) with low-volume warm blood cardioplegia were used in patients with body surface area less than 1.75 m2. Results. The use of low-volume oxygenators allowed to decrease blood transfusions while maintaining adequate hematocrit/hemoglobin during perfusion; early activation of the patient; reduction in transfusion requirements and TRALI. Conclusion. The patient-oriented selection of extracorporeal circuit reduces hemodilution, promoting hemodynamic stability and hemostasis and allows to use both low- and high-volume cardioplegia.

Authors:

Khaes B.L.

URAMN nauchno-issledovatel'skiĭ institut kompleksnykh problem serdechno-sosudistykh zabolevaniĭ SO RAMN, Kemerovo

Plotnikov G.P.

Research Institute for Complex Issues of Cardiovascular Diseases 6, Sosnovy Blvd, 650002, Kemerovo, Russia

Fanaskova E.V.

FGBU "NII kompleksnykh problem serdechno-sosudistykh zabolevaniĭ" SO RAMN, Kemerovo

Shukevich D.L.

Kemerovskaia oblastnaia klinicheskaia bol'nitsa

Barbarash L.S.

State Research Institute for Complex Issues of Cardiovascular Diseases Municipal Budget Healthcare Institution, Kemerovo, Russia

Close metadata

References:

  1. Ranucci M, Pazzaglia A, Bianchini C, Bozzetti G, Isgro G. Body size, gender, and transfusions as determinants of outcome after coronary operations. Ann Thorac Surg. 2008;85:481-486. doi: 10.1016/j.athoracsur.2007.10.014
  2. Koch CG, Li L, Sessler DI, et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med. 2008;358:1229-1239. doi: 10.1056/NEJMoa070403
  3. Engoren MC, Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ. Effect of blood transfusion on long-term survival after cardiac operation. Ann Thorac Surg. 2002;74:1180-1186. doi: 10.1016/S0003-4975(02)03766-9
  4. Karkouti K, O’Farrell R, Yau TM, Beattie WS. Prediction of massive blood transfusion in cardiac surgery. Can J Anaesth. 2006;53:781-794. doi: 10.1007/BF03022795
  5. Zangrillo A, Garozzo FA, Biondi-Zoccai G, et al. Miniaturized cardiopulmonary bypass improves short-term outcome in cardiac surgery: a metaanalysis of randomized controlled studies. J ThoracCardiovasc Surg. 2010;139:1162-1169. doi: 10.1016/j.jtcvs.2009.07.048
  6. McCusker K, Vijay V, DeBois W, Helm R, Sisto D. MAST system: a new condensed cardiopulmonary bypass circuit for adult cardiac surgery. Perfusion. 2001;16:447-452. doi: 10.1177/026765910101600603
  7. Best Care at Lower Cost: The Path to Continuously Learning Health Care in America. Washington, DC: The National Academies Press. 2012.
  8. Bronson SL, Riley JB, Blessing JP, et al. Prescriptive Patient Extracorporeal Circuit and Oxygenator Sizing Reduces Hemodilution and Allogeneic Blood Product Transfusion during Adult Cardiac Surgery. J Extra Corpor Technol. 2013;45:167-172.
  9. Loor G, Li L, Sabik JF3rd, et al. Nadir hematocrit during cardiopulmonary bypass: End-organ dysfunction and mortality. J Thorac Cardiovasc Surg. 2012;144:654-662. doi: 10.1016/j.jtcvs.2012.03.058
  10. Zhiburt EB, Shestakov EA. Regulations and Audit for Blood Transfusion. Guidelines for Physicians. M.: Natural Sciences. 2010;347 (In Russ.)
  11. Godier A, Samama CM, Susen S. Management of massive bleeding in 2013: seven questions and answers. Transfus Clin Biol. 2013;209(2):55-58.
  12. Stammers AH, Trowbridge CC, Pezzuto J, Casale A. Perfusion quality improvement and the reduction of clinical variability. J Extra Corpor Technol. 2009;41:48-58.
  13. Paltsev M. Personalized Medicine. Science in Russia. 2011;1:12-17 (In Russ.).
  14. Deptula J, Valleley M., Glogowski K, et al. Clinical Evaluation of the Terumo CAPIOX FX05 Hollow Fiber Oxygenator with Integrated Arterial Line Filter. JECT. 2009;41:220-225.
  15. Argerakis LPW, Johnson KA, et al. A retrospective comparison of blood transfusion requirements during cardiopulmonary bypass with two different small adult oxygenators. Perfusion. 2013;28:541-545. doi: 10.1177/0267659113492835
  16. Bakker EWM, Visser K. An in vitro comparison of bubble elimination in Quadrox and CAPIOX oxygenators. NeSECCUptodate. 2011;1:20-27.
  17. Lin J, Dogal MN, Mathis RK, et al. Evaluation of Qadrox-I and Capiox FX neonatal oxygenators with integrated arterial filters in eliminating gaseous microembolia end retaining hemodynamic properties during cardiopulmonary bypass. Perfusion. 2012;27:235-243.
  18. Preston TJ, Gomez B, Olshove VF, et al. Clinical GazeousMicroemboli Assessment of an Oxygenator with Integral Arterial Filter in the Pediatric Population. JECT. 2009;41:226-230.
  19. Hilberath J, Smith T, Jara C, et al. Blood volumes in cardiac surgery with cardiopulmonary bypass. Perfusion. 2014 Sep 23. doi: 10.1177/0267659114550230
  20. Hilberath J, Thomas M, Smith T, et al. Blood volume measurement by hemodilution: Association with valve disease and reevaluation of the Allen Formula. Perfusion. 2014 Aug 14. doi: 10.1177/0267659114547250
  21. Campbell JA, Holt DW, Shostrom VK, et al. Influence of intraoperative fluid volume on cardiopulmonary bypass hematocrit and blood transfusions in coronary artery bypass surgery. J Extra Corpor Technol. 2008;40:99-108.
  22. Testani JM, Brisco MA, Chen J, et al. Timing of hemoconcentracion during treatment of acute decompensated heart failure and susquent survival: Importance of sustained decongestion. J Am Coll Cardiol. 2013;62:516-524.
  23. DiMarco A, Velez H, Soltero E, et al. Lowest safe hematocrit level on cardiopulmonary bypass in patients undergoing coronary artery bypass grafting. Bol Asoc Med PR. 2011;103:25-29.
  24. Hogan M, Klein AA, Richard T. The impact of anemia and intravenous iron replacement therapy on outcomes in cardiac surgery. Eur J Cardiothorac Surg. 2015;47:218-226.
  25. 25.onk AB, Meesters MI, van Dijk WB, et al. Ten-year patterns in blood product utilization during cardiothoracic surgery with cardiopulmonary bypass in a tertiary hospital. Transfosion. 2014;54(10 Pt 2):2608-2616.
  26. Von Segesser LK, Tozzi P, Mallbiabrrena I,et al. Miniaturization in cardiopulmonary bypass. Perfusion. 2003;18:219-224. doi: 10.1111/trf.12522
  27. Baikousis NG, Papakonstaninou NA, Apostaolakis E. The «benefis» of the mini-extracorporeal circulaction in the minimal invasive cardiac surgery era. J Cardiol. 2014;63:391-396.
  28. Wang S, Palanzo D, Undar A. Current ultrafiltration techmicques before, during fnd pediatric cardiopylmonarybepassproctdures. Perfusion. 2012;27:438-446.
  29. Murphy GJ, Allen SM, Unwsworth-White J, et al. Safety and efficacy of perioperative cells salvage and autotransfusonaafter coronary artery bypass grafuing: a randomized trial. Ann Thorac Surg. 77;1553-1559.
  30. Myers GJ. Understanding Off-Label Use and Reference Blood Flows in Modern Membrane Oxygenators. J Extra Corpor Technol. 2014 Sep;46(3):192-196.
  31. Fact Sheet, The National Task Force on CME Provider/Industry Collaboration. On-label and off-label usage of prescription medicines and devices, and the relationship to CME. Available at:www.amaassn.org/resources/doc/cme/fact-sheet-4.pdf AccessedApril 2, 2014
  32. Liu S, Newland RF, Tully PJ, et al. In vitro evaluation of gaseous microemboli handling of cardiopulmonary bypass circuits with and without integrated arterial line filters. J Extracorp Techn. 2011;43:107-114. [PMC free article] [PubMed]
  33. Dogal NM, Mathis RK, Lin J, et al. Evaluation of three hollow-fiber membrane oxygenators without integrated arterial filters for neonatal cardiopulmonary bypass. Perfusion. 2012;27:132-140. [PubMed] doi: 10.1177/0267659111430560
  34. Myers GJ. Predictive Hemodilution: The Principle and Practice of Hemodilution During Cardiac Surgery. Mirandola, Italy: Sorin Perfusion Books, Sorin Group. 2013.
  35. Chappell D, Jacob M, Hofmann-Kiefer K, et al. A rational approach to perioperative fluid management. Anaesthesiology. 2008;109:723-740. [PubMed] doi: 10.1097/ALN.0b013e3181863117
  36. Strunden MS, Heckel K, Goetz AE, Reuter DA. Perioperative fluid and volume management: Physiological basis, tools and strategies. Ann Intensive Care. 2011;1:1-8. [PMCfreearticle] [PubMed] doi: 10.1186/2110-5820-1-2
  37. Klepinski R. Off-label use of medical devices in the USA. Journal Med Device Reg. 2009;6:8-19.
  38. US. Department of Health and Human Services (FDA). Off-label and investigational use of marketed drugs, biologics, and medical devices. 2011. Available at:www. fda. gov / RegulatoryInformation / Guidances / ucm 126486. htm
  39. Canadian Medical Protective Association. Risk management when using drugs or medical devices off-label. 2012. Available at: https://oplfrpd5.cmpa-acpm.ca/safety/-/asset_publisher/N6oEDMrzRbCC/content/risk-management-when-using-drugs-or-medical-devices-offlabel;jsessionid=B58C5E6D2B33B3452111CD59E85CC698
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.